Jim M Wild Selected Research

4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acid

7/2013	3D contrast-enhanced lung perfusion MRI is an effective screening tool for chronic thromboembolic pulmonary hypertension: results from the ASPIRE Registry.
2/2012	Diagnostic accuracy of contrast-enhanced MR angiography and unenhanced proton MR imaging compared with CT pulmonary angiography in chronic thromboembolic pulmonary hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jim M Wild Research Topics

Disease

8	Pulmonary Hypertension 01/2018 - 02/2012
7	Lung Diseases (Lung Disease) 05/2024 - 04/2007
6	Idiopathic Pulmonary Fibrosis 07/2023 - 01/2019
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 05/2007
5	Chronic Obstructive Pulmonary Disease (COPD) 02/2022 - 04/2005
3	COVID-19 12/2023 - 10/2021
3	Disease Progression 04/2022 - 03/2019
3	Fibrosis (Cirrhosis) 01/2022 - 06/2018
3	Asthma (Bronchial Asthma) 07/2021 - 01/2017
2	Infections 12/2023 - 10/2021
2	Inflammation (Inflammations) 03/2023 - 11/2020
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023 - 10/2016
2	Emphysema 01/2022 - 06/2013
2	Cicatrix (Scar) 10/2021 - 06/2018
2	Pulmonary Arterial Hypertension 10/2021 - 04/2021
2	Pneumonia (Pneumonitis) 10/2021 - 11/2010
2	Lung Neoplasms (Lung Cancer) 03/2019 - 08/2017
2	Cystic Fibrosis (Mucoviscidosis) 11/2018 - 11/2009
1	Respiratory Tract Diseases (Respiratory Tract Disease) 12/2023
1	Stroke (Strokes) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Atherosclerosis 01/2022
1	Dyspnea (Shortness of Breath) 10/2021
1	Infarction (Infarctions) 10/2021
1	Vascular Diseases (Vascular Disease) 01/2021
1	Edema (Dropsy) 06/2018
1	Familial Primary Pulmonary Hypertension 01/2014
1	Thrombosis (Thrombus) 02/2012
1	Pathologic Constriction (Stenosis) 02/2012
1	Pulmonary Embolism 02/2012
1	Lung Injury 11/2010

Drug/Important Bio-Agent (IBA)

5	XenonIBA 05/2024 - 03/2019
5	GadoliniumIBA 02/2022 - 06/2012
5	Helium-3IBA 11/2018 - 04/2005
4	Carbon MonoxideIBA 01/2022 - 06/2013
3	Xenon-129IBA 07/2023 - 01/2021
3	Oxygen (Dioxygen)IBA 01/2023 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2019
3	HeliumIBA 01/2022 - 01/2017
3	Protons (Proton)IBA 11/2020 - 04/2005
2	Bronchodilator Agents (Bronchodilators)IBA 01/2021 - 01/2017
2	ElementsIBA 01/2021 - 10/2016
2	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 07/2013 - 02/2012
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2023
1	Muscarinic AntagonistsIBA 02/2022
1	indacaterolIBA 02/2022
1	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 02/2022
1	fendosalIBA 01/2022
1	IronIBA 06/2018
1	Contrast MediaIBA 06/2018
1	Amyloidogenic ProteinsIBA 06/2018

Therapy/Procedure

9	Therapeutics 04/2022 - 04/2007
6	Radiotherapy 01/2024 - 05/2007
2	Endarterectomy (Thromboendarterectomy) 01/2018 - 09/2014
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 10/2009 - 05/2007
1	Ambulatory Care (Outpatient Care) 12/2023
1	Wearable Electronic Devices 12/2023
1	Precision Medicine 11/2020
1	Catheters 06/2013
1	Cardiac Catheters 03/2012